Lexaria Bioscience (LEXX) Payables (2016 - 2025)
Historic Payables for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to $1.4 million.
- Lexaria Bioscience's Payables rose 42992.83% to $1.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $1.4 million, marking a year-over-year increase of 42992.83%. This contributed to the annual value of $1.5 million for FY2025, which is 3719.37% up from last year.
- Per Lexaria Bioscience's latest filing, its Payables stood at $1.4 million for Q4 2025, which was up 42992.83% from $1.5 million recorded in Q3 2025.
- In the past 5 years, Lexaria Bioscience's Payables ranged from a high of $1.8 million in Q1 2025 and a low of $55318.0 during Q1 2024
- Over the past 5 years, Lexaria Bioscience's median Payables value was $189659.0 (recorded in 2021), while the average stood at $524725.0.
- Its Payables has fluctuated over the past 5 years, first tumbled by 8741.8% in 2024, then skyrocketed by 314140.24% in 2025.
- Lexaria Bioscience's Payables (Quarter) stood at $189542.0 in 2021, then increased by 27.62% to $241891.0 in 2022, then crashed by 59.09% to $98969.0 in 2023, then soared by 171.79% to $268986.0 in 2024, then soared by 429.93% to $1.4 million in 2025.
- Its Payables was $1.4 million in Q4 2025, compared to $1.5 million in Q3 2025 and $1.5 million in Q2 2025.